Yokohama, Japan

Jun Nagura

This inventor holds 1 USPTO granted patent. Top assignee: Meiji Seika Kabushiki Kaisha. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Nagura. Retrieved from https://idiyas.com/inventor/jun-nagura-mx14p8yy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jun Nagura

Introduction

Jun Nagura is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic potential.

Latest Patents

One of Jun Nagura's key patents is focused on pyridine derivatives that exhibit angiotensin II antagonism. This innovation has implications for treating various cardiovascular conditions, showcasing his expertise in medicinal chemistry. He holds 1 patent in this area.

Career Highlights

Jun Nagura is currently employed at Meiji Seika Kabushiki Kaisha, a company known for its commitment to research and development in the pharmaceutical industry. His work there has allowed him to explore new avenues in drug development and contribute to advancements in healthcare.

Collaborations

Throughout his career, Jun has collaborated with talented individuals such as Kiyoaki Katano and Hiroko Ogino. Their combined efforts have fostered a creative environment that encourages innovation and the pursuit of groundbreaking solutions.

Conclusion

Jun Nagura's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor in the industry. His work continues to impact the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…